Business Context and Reporting Period
Company: cbdMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 13, 2020
Reporting Period: Event-based (July 13, 2020)
Business Overview: cbdMD, Inc. is an emerging growth company incorporated in North Carolina, trading on the NYSE American under the symbols YCBD and YCBD PR A.
Key Financial Metrics
This filing is a current report regarding a specific corporate event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material event reported is the filing of a new patent application with the U.S. Patent and Trademark Office on July 13, 2020. The application seeks patent protection for a wide range of novel CBD technologies and methods.
Guidance, Outlook, and Risks
Management Commentary: The company issued a press release (Exhibit 99.1) announcing the patent filing to highlight its innovation in CBD technologies.
Regulatory Note: Pursuant to General Instruction B.2 of Form 8-K, the information in Item 7.01 and Exhibit 99.1 is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934. It is not incorporated by reference into other filings.
Investor Verification Checklist
- Verify the status and scope of the new patent application filed with the U.S. Patent and Trademark Office.
- Review the full text of the press release furnished as Exhibit 99.1 for specific details on the novel CBD technologies.
- Confirm that the patent filing does not immediately impact current financial performance or liquidity.
- Monitor future filings for updates on the patent approval process or related intellectual property developments.